Page last updated: 2024-10-16

5-hydroxytryptophan and Ventricular Fibrillation

5-hydroxytryptophan has been researched along with Ventricular Fibrillation in 2 studies

5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.

Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rabinowitz, SH1
Lown, B2
Lehnert, H1
Lombardi, F1
Raeder, EA1
Lorenzo, AV1
Verrier, RL1
Wurtman, RJ1

Other Studies

2 other studies available for 5-hydroxytryptophan and Ventricular Fibrillation

ArticleYear
Central neurochemical factors related to serotonin metabolism and cardiac ventricular vulnerability for repetitive electrical activity.
    The American journal of cardiology, 1978, Volume: 41, Issue:3

    Topics: 5-Hydroxytryptophan; Animals; Blood Pressure; Carbidopa; Cardiac Complexes, Premature; Cardiac Pacin

1978
Increased release of brain serotonin reduces vulnerability to ventricular fibrillation in the cat.
    Journal of cardiovascular pharmacology, 1987, Volume: 10, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Blood Pressure; Carbidopa; Cats; Coron

1987